EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieKohortenstudie

Rate of vertical transmission of coronavirus disease 2019 and effect of maternal vaccination: A prospective cohort study

Satoshi Matsunashi, Hiroyuki Unoki-Kubota, Takehiro Sugiyama, Kei Yamamoto, Shinsuke Ebihara, Nobuko Nishioka, Kaoru Okazaki iD, Izumi Honda, Kohei Kashima iD, Hiroko Arai, Yayoi Murano iD, Ichiro Morioka iD und 8 weitere

Pediatrics International · 2025-01 · 67 (1)

DOI: 10.1111/ped.15892 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Pediatrics International, online erschienen am 28.02.2025. Verfasst von Satoshi Matsunashi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Infectious Disease Transmission, Vertical, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Masato Kawano Memorial Public Interest Foundation for Promotion of Pediatrics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to reveal the transmission rate of coronavirus disease 2019 (COVID‐19) and clinical features of congenital and neonatal COVID‐19 and to disclose the efficacy of maternally transferred antibodies by maternal vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2).

Methods

This multicenter, prospective observational study included a comprehensive testing protocol with appropriate precautions. Mothers and infants were enrolled and classified into an active infection group (mothers with COVID‐19 at delivery), a postinfection group (mothers recovered from COVID‐19 during pregnancy), and a vaccination group (mothers vaccinated during pregnancy). Specimen collections, polymerase chain reaction assays, anti‐SARS‐CoV‐2 antibody measurements, and clinical examinations were conducted for 6 months from delivery.

Results

Sixty‐nine mothers and 70 infants were enrolled. SARS‐CoV‐2 was detected in the placenta in 22% of the active infection group and in 21% of the postinfection group. Neither SARS‐CoV‐2 nor SARS‐CoV‐2‐specific IgM was detected in infants. No anomalies, functional disorders, or developmental problems were observed in infants for 6 months. Compared with the postinfection group, there was a significant increase in maternally transferred antibody titers in the vaccination group according to the number of vaccinations, which was maintained for longer than the first month of life.

Conclusions

Vertical transmission of COVID‐19 was not observed despite a comprehensive testing protocol. SARS‐CoV‐2 was detected more often in the placenta, which appeared to prevent vertical transmission. Maternal vaccination increased maternally transferred antibody titers in infants and was considered immunologically efficient. Vaccination during pregnancy is considered important for preventing congenital, neonatal, and infantile COVID‐19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousVaccinationAdultFemaleHumansInfantInfant, NewbornMalePregnancyAntibodies, ViralImmunity, Maternally-AcquiredProspective StudiesSARS-CoV-2

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2clinical research protocolvaccinationvertical transmission

Substanzen

Antibodies, ViralCOVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Pediatrics, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Department of Diabetic Complications, Diabetes Research Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Diabetes and Metabolism Information Center, Research Institute, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Institute for Global Health Policy Research, Bureau of International Health Cooperation, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
  • Department of Health Services Research, Institute of Medicine, University of Tsukuba, Tsukuba-shi, Ibaraki, Japan.
  • Disease Control and Prevention Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.

ORCID-Profile: Kaoru Okazaki, Kohei Kashima, Yayoi Murano, Ichiro Morioka, Tomohisa Akamatsu

Förderung

  • Masato Kawano Memorial Public Interest Foundation for Promotion of Pediatrics

Zitieren

APA

Matsunashi, S., Unoki-Kubota, H., Sugiyama, T., Yamamoto, K., Ebihara, S., Nishioka, N., Okazaki, K., Honda, I., Kashima, K., Arai, H., Murano, Y., Morioka, I., Sadatsuki, M., Oishi, H., Mochizuki, S., Kaburagi, Y., Shichino, H., Namba, F., Kato, N., & Akamatsu, T. (2025). Rate of vertical transmission of coronavirus disease 2019 and effect of maternal vaccination: A prospective cohort study. Pediatrics International, 67(1). https://doi.org/10.1111/ped.15892

Vancouver

Matsunashi S, Unoki-Kubota H, Sugiyama T, Yamamoto K, Ebihara S, Nishioka N, et al. Rate of vertical transmission of coronavirus disease 2019 and effect of maternal vaccination: A prospective cohort study. Pediatrics International. 2025;67(1). doi:10.1111/ped.15892

BibTeX
@article{Matsunashi2025,
  author = {Matsunashi, Satoshi and Unoki-Kubota, Hiroyuki and Sugiyama, Takehiro and Yamamoto, Kei and Ebihara, Shinsuke and Nishioka, Nobuko and Okazaki, Kaoru and Honda, Izumi and Kashima, Kohei and Arai, Hiroko and Murano, Yayoi and Morioka, Ichiro and Sadatsuki, Miyuki and Oishi, Hajime and Mochizuki, Shinji and Kaburagi, Yasushi and Shichino, Hiroyuki and Namba, Fumihiko and Kato, Norihiro and Akamatsu, Tomohisa},
  title = {Rate of vertical transmission of coronavirus disease 2019 and effect of maternal vaccination: A prospective cohort study},
  journal = {Pediatrics International},
  year = {2025},
  volume = {67},
  number = {1},
  doi = {10.1111/ped.15892}
}
Kostenlos starten →